MTOR and Parkinson disease: This may also explain why genetic ablation of MTOR does not phenocopy rapamycin, and why Torin, a much stronger mTORC1 inhibitor that does not activate TRPML1 22, lacks protective effects on neuron death in in vivo models of Parkinson disease 63.